Bulk Peptide Synthesis for Research and Industrial Use

Name: Bulk Peptide Synthesis for Research and Industrial Use
Brand: Beijing Lingyan Biotechnology Co., Ltd.
SKU: 2155974692

Beijing, ChinaBeijing Lingyan Biotechnology Co., Ltd.

US$50.00

10 Sets

Product specifications

color

dose

appearance

Sample price:US$60.00/piece.Request sample

Product profile

Customization

Available

Classification

Peptide Intermediates

Specific Usage

Pro Analysis, for Research Use

Model NO.

peptide powder

Content

Standard

Usage

Analytical Reagents

Source

Dry Powder

Habit Appellation

Health Reagents

Application

Health

Property

Biochemical Reagent

Suitable for

Adult

Model

CAS

Side Effect

Private Customization

Available

Transport Package

Box

Specification

10vials/box

Trademark

LingYan

Origin

China

HS Code

2933360000

Production Capacity

10000/Day

Company profile

Importers and ExportersHigh Repeat Buyers ChoiceFast DeliveryLow MOQ

Beijing Lingyan Biotechnology Co., Ltd.

Beijing, China

CertifiedBusiness Type: Trading Company CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc.Export Year: 2025-06-03Nearest Port: HongKongAverage Response Time: ≤6.94hTerms of Payment: T/T, LC

AI-Powered supplier vetting

SummaryThe supplier specializes in flexible production models supporting biotechnology, pharmaceutical, and life sciences industries. They provide comprehensive manufacturing services, from small-scale research to large-scale production. However, the supplier lacks ODM and OEM services for well-known brands and international presence. Despite having clear procedures for quality control and customer complaint handling, there is no evidence of financial activity, innovation, or overseas service capability.

Supplier typeThe supplier is involved in the biotechnology, pharmaceutical, and life science industries, offering OEM/ODM production and custom technical services.

After-Sales capabilityThe supplier has clear procedures and records for handling customer complaints and quality control, indicating a structured approach to after-sales service.

Financial creditThe supplier shows no operating revenue, profit, or financial activity over the last three years, indicating a potential lack of financial credibility.

R&D capabilityThere is no evidence of innovation capability as the supplier has not introduced new products or SDK availability in the past year.

Production capacityThe supplier offers comprehensive production capabilities, including recombinant protein expression, gene cloning, and large-scale manufacturing.

Customization capabilityThe supplier provides full customization services from designs and samples, reflecting strong customization capabilities.